Study to improve blood sugar and reduce inflammation
Part of Digestive system, Hormones & metabolism, Immune system & allergy clinical trials.
This study looks at how an intervention may improve blood sugar control and lower inflammation in the body. You may be able to take part unless you have a specific condition called celiac disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You do not have a diagnosis of celiac disease
- No other listed eligibility requirements were provided
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects information from people being checked for celiac disease to better understand the condition and improve diagnosis and treatment.
This study looks at how your immune system responds when you eat gluten, including for people with celiac disease. You may be asked to follow a gluten-free diet first and then safely reintroduce gluten so researchers can measure immune changes.
This study looks at adults with immune-related stomach and intestine problems to better understand what may cause them. If you qualify, you can share information and consent to help researchers learn how these conditions work.
This study looks at how the immune system of children with celiac disease responds to a small amount of gluten. It may help researchers understand the disease better and find new ways to monitor it.
This study tests an experimental medication for adults with celiac disease to see if it can protect against gluten exposure. You will need to follow a gluten-free diet and undergo a short, planned gluten challenge.
This study looks at how the gut lining “tissues” are affected during gluten eating versus avoiding gluten in people with celiac disease. It may help researchers understand what drives healing and tissue damage in celiac disease.
Hear when a new Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.